Ignite Creation Date:
2024-05-05 @ 6:33 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00501527
Status:
COMPLETED
Last Update Posted:
2010-12-17
First Post:
2007-07-13
Brief Title:
Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense
Sponsor:
Laboratorios Leti SL
Organization:
Laboratorios Leti SL
Study Overview
Official Title:
Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense in Patients Suffering From Allergic Rhinoconjunctivitis andor Asthma
Status:
COMPLETED
Status Verified Date:
2010-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this trial is to evaluate the clinical effectiveness of the administration of a depigmented and polymerized allergen extract of Phleum pratense in the rhinoconjunctivitis andor asthma of slight or moderate intensity due to allergy to grass pollen
Detailed Description:
Immunotherapy is a specific treatment for allergic diseases Unlike conventional pharmacological treatment immunotherapy is the only treatment that could modify the natural course of allergic disease This is a prospective double-blind placebo controlled study with three arms of treatment placebo and two active one of the active arms will receive a dose that is 10x the dose of the other arm
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 6078-PG-OSL-145 | OTHER | Sponsor Protocol number | None |